Australia's CSL invests $117 million for VarmX acquisition option, coagulation treatment – Reuters

Written by

admin

in

  1. Australia’s CSL invests $117 million for VarmX acquisition option, coagulation treatment  Reuters
  2. CSL makes $760m bet on Dutch bleeding disorder biotech  AFR
  3. CSL commits US$505M to VarmX blood coagulation treatment deal  Proactive financial news
  4. CSL (ASX:CSL) share price in focus on US$505 million partnership  Rask Media
  5. ASX Rises as CSL Invests $760 Million  Finance News Network

Continue Reading

More posts